ArticleMycopathologia2025
Exopolysaccharides of Ganoderma lucidum Activate the NLRP3 Inflammasome, Modulating Phagocytes and the Response of Mice to Infection with Cryptococcus neoformans.
Article in Mycopathologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Plant secondary metabolites exert therapeutic effects by modulating autophagy pathways.Frontiers in plant science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Interleucin-1β (IL-1β) is a pivotal cytokine in pro-inflammatory response induction, and it is regarded as protective in various diseases. IL-1β secretion is mainly associated with activation of the inflammasome complex, which normally is tightly regulated, depending on two signals for significant activity. The water insoluble fraction of the mushroom Ganoderma lucidum was extracted and co-cultivated with murine bone-marrow macrophages. We demonstrated that G. lucidum exopolysaccharides (EPS) were able to induce IL-1β production and release in murine macrophages. The mechanisms underlying EPS-induced priming encompass recognition through dectin-1 and activation of the spleen tyrosine kinase (Syk)/nuclear factor kappa-light-chain-enhancer of the activated B (NF-kB) axis. In addition, EPS stimulates IL-1β secretion in a phagocytosis-dependent manner via the NLR family pyrin domain containing 3 (NLRP3) inflammasome activation in response to reactive oxygen species production, potassium efflux, phagolysosomal acidification, and cathepsin B release. Both caspase-1 and, to a lesser extent, caspase-8 were activated upon EPS stimulus and required for IL-1β cleavage and release. Lastly, EPS stimulated phagocytes' anticryptococcal activity in vitro, reducing intracellular fungal burden in dendritic cells. Moreover, oral treatment with EPS improved mice's survival in a cryptococcosis model. Our study highlighted significant stimulation by G. lucidum EPS to innate immune cells and improved its fungicidal activity, protecting the host in a murine model of infection, suggesting a potential adjuvant in antimicrobial treatment schemes.
Indexed as
Identifiers
40450627What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.